Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme Omda AS (“Omda” or the “Company”) (Ticker: Omda NO).

Date on which the share buy-back programme was announced: 30 November 2022.

The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.

Aggregated overview of transactions per day:

DateAggregate daily volume (# of shares)Weighted average price (NOK)Total transaction value (NOK)
01/11/2023 00:00:004,75729.9874142,650.00
02/11/2023 00:00:004,79430.1726144,647.30
03/11/2023 00:00:003,82829.7011113,696.00
06/11/2023 00:00:003,75629.6906111,517.80
07/11/2023 00:00:004,91129.8947146,812.90
08/11/2023 00:00:0019,24828.1374541,589.00
09/11/2023 00:00:006,77728.7298194,702.00
Previously disclosed buy-backs under the programme (aggregate)350,41137.868613,269,586.07
Total purchased under the programme398,48236.802714,665,201.07

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report. Download appendix.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About Omda

Omda is the leading provider of specialised software for healthcare in the Nordics with a growing presence in Europe, North America and the Pacific region. The company serves more than 500 customers in 27 countries and employs almost 300 dedicated specialists. Our highly specialised healthcare solutions empower medical professionals and emergency responders, enabling them to know more and work smarter. With a focus on user-centric design, value-driven development and close working relationships with customers, Omda delivers solutions that enhance patient safety and improve healthcare outcomes.

Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoO

Einar Bonnevie
Chief Financial Officer
Categories

Related News

Omda AS completes share buyback programme
Read More
Transactions carried out under the share buy-back programme
Read More
Partial repurchase of OMDA01
Read More
Announcement of successful placement of new secured bond issue
Read More

Get in touch

Please enable JavaScript in your browser to complete this form.
Name
Helen Døcker
Chief Marketing & Communications Officer
helen.docker@omda.com
She is based in the company’s headquarters in Oslo, Norway.

Join our conversation to build a safer and healthier world.